These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8994247

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The effect of weight correction on risk calculations for Down's syndrome screening.
    Reynolds TM, Penney MD, Hughes H, John R.
    Ann Clin Biochem; 1991 May; 28 ( Pt 3)():245-9. PubMed ID: 1714686
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Specificity of biochemical markers of pregnancy second trimester].
    Salazar López R, Ibarra Gallardo AL, Iduma Meléndrez M, Leyva Bojórquez R.
    Ginecol Obstet Mex; 2007 Oct; 75(10):608-14. PubMed ID: 18800579
    [Abstract] [Full Text] [Related]

  • 26. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
    Huang T, Owolabi T, Summers AM, Meier C, Wyatt PR.
    Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
    [Abstract] [Full Text] [Related]

  • 27. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S, Chandeying V.
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [Abstract] [Full Text] [Related]

  • 28. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA, Crossley JA.
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [Abstract] [Full Text] [Related]

  • 29. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection].
    Christiansen M, Larsen SO, Nørgaard-Pedersen B.
    Lakartidningen; 1997 Dec 17; 94(51-52):4898-902. PubMed ID: 9454010
    [Abstract] [Full Text] [Related]

  • 30. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J, Skrablin S, Durić K, Suchanek E, Muzinić D, Kalafatić D, Kuvacić I, Zlopasa G, Plavec A.
    Lijec Vjesn; 2003 Dec 17; 125(3-4):55-60. PubMed ID: 12899094
    [Abstract] [Full Text] [Related]

  • 31. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels.
    Cowans NJ, Spencer K.
    Prenat Diagn; 2005 Aug 17; 25(8):693-9. PubMed ID: 16050001
    [Abstract] [Full Text] [Related]

  • 32. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T, Ellis A, Jones R.
    Ann Clin Biochem; 2004 Nov 17; 41(Pt 6):464-8. PubMed ID: 15588435
    [Abstract] [Full Text] [Related]

  • 33. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE.
    Semin Perinatol; 1990 Dec 17; 14(6):488-503. PubMed ID: 1706536
    [No Abstract] [Full Text] [Related]

  • 34. [Evaluating the applicability of MoM in second trimester maternal serum to screening for Down's syndrome in Jiangsu province].
    Xu BY, Hu Y, Zhang CY, Zhang JW, Liu QL, Yue H, Ru T, Xu ZF, Zhu RF, Zhang Y, Zhong X, Wu QM.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb 17; 25(1):32-5. PubMed ID: 18247300
    [Abstract] [Full Text] [Related]

  • 35. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
    Christiansen M, Høgdall EV, Larsen SO, Høgdall C.
    Prenat Diagn; 2002 May 17; 22(5):385-7. PubMed ID: 12001192
    [Abstract] [Full Text] [Related]

  • 36. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO, Oz U, Shahabi S, Mahoney MJ, Baumgarten A, Cole LA.
    Am J Obstet Gynecol; 2000 Nov 17; 183(5):1114-8. PubMed ID: 11084551
    [Abstract] [Full Text] [Related]

  • 37. [Triple test: problem or enhancement of prenatal diagnosis].
    Rauskolb R, Engel W.
    Z Geburtshilfe Neonatol; 1995 Nov 17; 199(3):91. PubMed ID: 7553260
    [No Abstract] [Full Text] [Related]

  • 38. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
    Huang T, Boucher K, Summers AM.
    Prenat Diagn; 2007 Dec 17; 27(12):1138-42. PubMed ID: 17960787
    [Abstract] [Full Text] [Related]

  • 39. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A.
    Prenat Diagn; 2005 Dec 17; 25(12):1102-6. PubMed ID: 16231324
    [Abstract] [Full Text] [Related]

  • 40. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD, McIntosh SF, Halstead AC.
    Prenat Diagn; 2005 Mar 17; 25(3):234-8. PubMed ID: 15791658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.